SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 247.88M EUR in the quarter ending March 31, 2026, a decrease of -1.51%. This brings the company's revenue in the last twelve months to 991.22M, up 1.80% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.

• Revenue (ttm): 991.22M
• Revenue Growth: +1.80%
• P/S Ratio: 2.59
• Revenue / Employee: 204.84K
• Employees: 4,829
• Market Cap: 2.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	986.21M	29.12M	3.04%
Sep 30, 2024	957.09M	58.49M	6.51%
Sep 30, 2023	898.60M	77.46M	9.43%
Sep 30, 2022	821.14M	172.48M	26.59%
Sep 30, 2021	648.67M	64.44M	11.03%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error